Intensity Therapeutics, Inc. (INTS)
Intensity Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
2,222,223
Deal Size
$10.00M
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin
|
1.17 | 1.24 |
| Research & Development
|
5.05 | 4.44 |
| Operating Expenses
|
6.22 | 5.68 |
| Operating Income
|
-6.22 | -5.68 |
| Interest Expense / Income
|
-0.07 | -0.15 |
| Other Expense / Income
|
-0.12 | -0.14 |
| Pretax Income
|
-6.03 | -5.38 |
| Net Income
|
-6.03 | -5.38 |
| Net Income Common
|
-6.03 | -5.38 |
| EBITDA
|
-6.1 | -5.53 |
| EBIT
|
-6.1 | -5.53 |
Source: IPO financials are sourced from
S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).